Jeffrey E. Gershenwald MD, FACS

Jeffrey E. Gershenwald, M.D., is a surgical oncologist-investigator in the melanoma field. In addition to his melanoma clinical practice and leadership role in the Melanoma and Skin Center, he has an active research program that's focused on integrating clinical, pathological, molecular and immune factors to improve melanoma staging and develop clinical tools to improve clinical decision-making for patients with melanoma.

Dr. Gershenwald received his M.D. from Cornell University Medical College, and after completing his general surgery residency at The New York Hospital-Cornell Medical Center, he completed a fellowship in Surgical Oncology at MD Anderson before joining its faculty.

Dr. Gershenwald co-led the melanoma project of The NIH-funded Cancer Genome Atlas (TCGA) program, an international team that performed the most comprehensive molecular analysis of melanoma to date. He has published more than 200 articles in peer-reviewed journals, more than 100 editorials, invited articles, book chapters, and other publications.